- Home
- ADT vs TECH Comparison
ADT vs TECH Comparison
Compare ADT & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADT
- TECH
- Stock Information
- Founded
- ADT 1874
- TECH 1976
- Country
- ADT United States
- TECH United States
- Employees
- ADT N/A
- TECH N/A
- Industry
- ADT Diversified Commercial Services
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ADT Consumer Discretionary
- TECH Health Care
- Exchange
- ADT Nasdaq
- TECH Nasdaq
- Market Cap
- ADT 7.0B
- TECH 7.8B
- IPO Year
- ADT 2018
- TECH 1989
- Fundamental
- Price
- ADT $8.38
- TECH $51.42
- Analyst Decision
- ADT Buy
- TECH Buy
- Analyst Count
- ADT 4
- TECH 12
- Target Price
- ADT $9.05
- TECH $70.00
- AVG Volume (30 Days)
- ADT 14.5M
- TECH 1.9M
- Earning Date
- ADT 07-24-2025
- TECH 08-06-2025
- Dividend Yield
- ADT 2.57%
- TECH 0.62%
- EPS Growth
- ADT N/A
- TECH N/A
- EPS
- ADT 0.59
- TECH 0.83
- Revenue
- ADT $4,976,265,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- ADT $5.95
- TECH $7.07
- Revenue Next Year
- ADT $4.34
- TECH $5.72
- P/E Ratio
- ADT $13.34
- TECH $62.04
- Revenue Growth
- ADT 5.65
- TECH 4.72
- 52 Week Low
- ADT $6.53
- TECH $46.01
- 52 Week High
- ADT $8.72
- TECH $83.62
- Technical
- Relative Strength Index (RSI)
- ADT 49.42
- TECH 48.96
- Support Level
- ADT $8.35
- TECH $50.97
- Resistance Level
- ADT $8.60
- TECH $55.53
- Average True Range (ATR)
- ADT 0.13
- TECH 2.16
- MACD
- ADT 0.00
- TECH -0.01
- Stochastic Oscillator
- ADT 35.71
- TECH 34.35
About ADT ADT Inc.
ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name. The company segments include Consumer and Small Business (CSB).
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.